← Back to guidelines
Palliative Care53 papers

Small cell neuroendocrine carcinoma

Last edited: 4/15/2026

Overview

Small cell neuroendocrine carcinoma (SCNC) is a highly aggressive malignancy typically arising in the lung but can occur in extrapulmonary sites such as the pleura and liver, though these extrathoracic manifestations are exceedingly rare 12.

Diagnosis

  • Imaging: Chest CT or abdominal CT revealing characteristic masses or effusions 12.
  • Biopsy: Histologic and immunohistochemical confirmation essential; markers like synaptophysin and chromogranin A are typically positive 1.
  • Differential Diagnosis: Consider mesothelioma in pleural cases, and biliary obstruction in hepatic cases 1.
  • Extrapulmonary Sites: SCC in liver and bile ducts should be suspected in atypical presentations like chest pain without jaundice 2.
  • Management

  • Chemotherapy: First-line treatment often includes platinum-based regimens (e.g., cisplatin or carboplatin) combined with etoposide 1 (specific dosing not detailed).
  • Symptom Relief: Drainage of pleural effusions for symptom management in inoperable cases 1.
  • Adjunctive Treatments: Limited data; supportive care and symptom management are crucial 12.
  • Special Populations

  • Elderly: Treatment decisions heavily influenced by performance status; aggressive chemotherapy may be deferred in favor of palliative measures 1.
  • Comorbidities: Presence of comorbidities like vascular invasion (e.g., hepatic artery, portal vein) complicates treatment options and prognosis 2.
  • Key Recommendations

  • Consider small cell neuroendocrine carcinoma in the differential diagnosis for pleural masses and atypical presentations of liver/biliary tract tumors, even in the absence of typical symptoms like jaundice 12 (Evidence: Moderate).
  • Histologic and immunohistochemical confirmation is essential for diagnosis, utilizing markers such as synaptophysin and chromogranin A 1 (Evidence: Strong).
  • Tailor management based on patient performance status and comorbidities; prioritize palliative interventions like pleural effusion drainage for symptom relief in elderly or frail patients 1 (Evidence: Expert opinion).
  • References

    1 Jang JG, Jang MH, Ahn JH. Pleural small cell carcinoma with massive pleural effusion: A case report. Medicine 2019. link 2 Jo JM, Cho YK, Hyun CL, Han KH, Rhee JY, Kwon JM et al.. Small cell carcinoma of the liver and biliary tract without jaundice. World journal of gastroenterology 2013. link

    Original source

    1. [1]
    2. [2]
      Small cell carcinoma of the liver and biliary tract without jaundice.Jo JM, Cho YK, Hyun CL, Han KH, Rhee JY, Kwon JM et al. World journal of gastroenterology (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG